The Relative Impact of Urinary and Sexual Function vs Bother on Health Utility for Men With Prostate Cancer
- PMID: 33134826
- PMCID: PMC7583149
- DOI: 10.1093/jncics/pkaa044
The Relative Impact of Urinary and Sexual Function vs Bother on Health Utility for Men With Prostate Cancer
Abstract
Function and bother are related but distinct aspects of health-related quality of life. The objective of this study was to compare quantitatively the relative impacts of function and bother in urinary, sexual, and bowel outcomes on health utility as a reflection of health-related quality of life in men with prostate cancer. Our analysis included participants in the Cancer of the Prostate Strategic Urologic Research Endeavor utility supplementary study, with a final cohort of 1617 men. Linear regression on the patients' function and bother summary scores (0-100) from the University of California, Los Angeles Prostate Cancer Index was performed to predict bias-corrected health utilities. Urinary and sexual bother were associated with each health utility, and their coefficients were 3.7 and 20.8 times greater, respectively, than those of the corresponding function. To our knowledge, our study provides the first quantitative and direct comparison of the impacts of function vs bother on health utility.
© The Author(s) 2020. Published by Oxford University Press.
Similar articles
-
How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE.Urology. 2003 Jan;61(1):190-6. doi: 10.1016/s0090-4295(02)02118-0. Urology. 2003. PMID: 12559294
-
Life after radical prostatectomy: a longitudinal study.J Urol. 2001 Aug;166(2):587-92. J Urol. 2001. PMID: 11458073
-
Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor.Urology. 1999 Sep;54(3):503-8. doi: 10.1016/s0090-4295(99)00172-7. Urology. 1999. PMID: 10475362
-
The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.Urology. 2001 Aug;58(2 Suppl 1):94-100. doi: 10.1016/s0090-4295(01)01250-x. Urology. 2001. PMID: 11502459 Review.
-
Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population.Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):51-9. doi: 10.1016/s0360-3016(00)01365-1. Int J Radiat Oncol Biol Phys. 2001. PMID: 11163497 Review.
Cited by
-
Letter to the editor: Reply to Chen et al.Clin Transl Radiat Oncol. 2025 May 9;53:100979. doi: 10.1016/j.ctro.2025.100979. eCollection 2025 Jul. Clin Transl Radiat Oncol. 2025. PMID: 40476149 Free PMC article.
References
-
- Reeve BB, Potosky AL, Willis GB. Should function and bother be measured and reported separately for prostate cancer quality-of-life domains? Urology. 2006;68(3):599–603. - PubMed
-
- Cooperberg MR, Koppie TM, Lubeck DP, et al.How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE. Urology. 2003;61(1):190–196. - PubMed
-
- Le JD, Cooperberg MR, Sadetsky N, et al.Changes in specific domains of sexual function and sexual bother after radical prostatectomy. BJU Int. 2010;106(7):1022–1029. - PubMed